GT Bio

GT Bio is a seed-stage techbio startup building an AI-powered in vivo data engine for drug delivery. By combining expertise in drug delivery, targeted conjugates, spatial biology, and machine learning, the company is pioneering cell-type-specific delivery systems. Their mission is to enable precise, scalable, and affordable medicine for patients through their proprietary platform, Deliveromics, which discovers and engineers novel lipid and targeted formulations.